Teleflex Incorporated $TFX Shares Sold by Diamond Hill Capital Management Inc.

Diamond Hill Capital Management Inc. cut its stake in shares of Teleflex Incorporated (NYSE:TFX) by 22.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 329,036 shares of the medical technology company’s stock after selling 95,561 shares during the period. Diamond Hill Capital Management Inc.’s holdings in Teleflex were worth $40,261,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB raised its stake in shares of Teleflex by 57.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 77 shares during the period. Hantz Financial Services Inc. increased its stake in Teleflex by 248.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after buying an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Teleflex during the 3rd quarter worth $35,000. True Wealth Design LLC boosted its position in Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after buying an additional 310 shares during the last quarter. Finally, Quent Capital LLC purchased a new position in Teleflex in the 3rd quarter valued at about $38,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of TFX stock opened at $108.52 on Friday. The company has a market cap of $4.80 billion, a P/E ratio of -14.76, a PEG ratio of 1.41 and a beta of 0.92. The business has a 50 day moving average of $115.18 and a two-hundred day moving average of $119.34. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $180.58. The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.29. The business had revenue of $892.90 million for the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The business’s revenue was up 19.4% on a year-over-year basis. During the same quarter last year, the business posted $3.49 EPS. As a group, analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on TFX. Needham & Company LLC raised Teleflex from a “hold” rating to a “buy” rating and set a $138.00 target price on the stock in a research report on Tuesday, January 27th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Wall Street Zen lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Wells Fargo & Company reduced their price objective on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 29th. Finally, Truist Financial upped their target price on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday, December 18th. Two analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $139.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.